Julia A Haller - Net Worth and Insider Trading

Over the past 18 months, Julia A Haller made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 5,071 shares made by Christopher S. Boerner , a net sale of 50,385 shares made by Rupert Vessey , and a net sale of 17,986 shares made by Ann Powell Judge .

In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 69,103 shares of Bristol-Myers Squibb Co (BMY) were sold and 13,571 shares were bought by its insiders, resulting in a net sale of 55,532 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julia A Haller made no insider transaction in Eyenovia Inc (EYEN). Other recent insider transactions involving Eyenovia Inc (EYEN) include a net purchase of 1,839,115 shares made by Stuart M. Grant , a net sale of 270,000 shares made by Tsontcho Ianchulev , and a net purchase of 84,498 shares made by Michael M Rowe .

In summary, during the past 3 months, insiders sold 0 shares of Eyenovia Inc (EYEN) in total and bought 1,592,222 shares, with a net purchase of 1,592,222 shares. During the past 18 months, 270,000 shares of Eyenovia Inc (EYEN) were sold and 1,949,933 shares were bought by its insiders, resulting in a net purchase of 1,679,933 shares.

Eyenovia Inc (EYEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Julia A Haller made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net sale of 520,000 shares made by Terry Dagnon , a net purchase of 62,484 shares made by Jeff Evanson , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .

In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,000 shares of Outlook Therapeutics Inc (OTLK) were sold and 5,006 shares were bought by its insiders, resulting in a net sale of 20,994 shares.

Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.